AU2001260674A1 - TNF-alpha production inhibitors - Google Patents

TNF-alpha production inhibitors

Info

Publication number: AU2001260674A1
Authority: AU; Australia
Prior art keywords: tnf; alpha production; production inhibitors; inhibitors; alpha
Prior art date: 2000-05-31
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2001260674A

Other versions

AU2001260674B2 (en

Inventor

Masakazu Ban

Hiroshi Enomoto

Masato Horiuchi

Hiroyuki Inoue

Hiroshi Suhara

Noriyoshi Yamamoto

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ayumi Pharmaceutical Corp

Original Assignee

Ayumi Pharmaceutical Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-31

Filing date

2001-05-31

Publication date

2002-02-28

2001-05-31 Application filed by Ayumi Pharmaceutical Corp filed Critical Ayumi Pharmaceutical Corp

2001-05-31 Priority claimed from PCT/JP2001/004586 external-priority patent/WO2001092229A1/en

2002-02-28 Publication of AU2001260674A1 publication Critical patent/AU2001260674A1/en

2006-02-28 Priority to AU2006200864A priority Critical patent/AU2006200864B2/en

2006-03-30 Application granted granted Critical

2006-03-30 Publication of AU2001260674B2 publication Critical patent/AU2001260674B2/en

2016-03-24 Assigned to AYUMI PHARMACEUTICAL CORPORATION reassignment AYUMI PHARMACEUTICAL CORPORATION Request for Assignment Assignors: SANTEN PHARMACEUTICAL CO., LTD.

2021-05-31 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Links

AU2001260674A 2000-05-31 2001-05-31 Tnf-alpha production inhibitors Ceased AU2001260674B2 (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
AU2006200864A AU2006200864B2 (en)	2000-05-31	2006-02-28	TNF-alpha production inhibitors

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2000162945		2000-05-31
JP2000-162945		2000-05-31
PCT/JP2001/004586 WO2001092229A1 (en)	2000-05-31	2001-05-31	TNF-α PRODUCTION INHIBITORS

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2006200864A Division AU2006200864B2 (en)	2000-05-31	2006-02-28	TNF-alpha production inhibitors

Publications (2)

Publication Number	Publication Date
AU2001260674A1 true AU2001260674A1 (en)	2002-02-28
AU2001260674B2 AU2001260674B2 (en)	2006-03-30

Family

ID=18666780

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
AU6067401A Pending AU6067401A (en)	2000-05-31	2001-05-31	Tnf-alpha production inhibitors
AU2001260674A Ceased AU2001260674B2 (en)	2000-05-31	2001-05-31	Tnf-alpha production inhibitors
AU2006200864A Ceased AU2006200864B2 (en)	2000-05-31	2006-02-28	TNF-alpha production inhibitors

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AU6067401A Pending AU6067401A (en)	2000-05-31	2001-05-31	Tnf-alpha production inhibitors

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AU2006200864A Ceased AU2006200864B2 (en)	2000-05-31	2006-02-28	TNF-alpha production inhibitors

Country Status (15)

Country	Link
US (5)	US7098226B2 (en)
EP (4)	EP1302461B1 (en)
JP (4)	JP3867196B2 (en)
KR (2)	KR100978304B1 (en)
CN (3)	CN1284771C (en)
AT (4)	ATE374186T1 (en)
AU (3)	AU6067401A (en)
CA (2)	CA2736344A1 (en)
CY (1)	CY1107089T1 (en)
DE (4)	DE60127595T2 (en)
DK (1)	DK1302461T3 (en)
ES (4)	ES2353020T3 (en)
NO (2)	NO324472B1 (en)
PT (1)	PT1302461E (en)
WO (1)	WO2001092229A1 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1302461B1 (en) *	2000-05-31	2007-09-26	Santen Pharmaceutical Co., Ltd.	Tnf-alpha production inhibitors
CN100522150C (en) *	2001-11-30	2009-08-05	参天制药株式会社	Angiogenesis inhibitor
WO2003077847A2 (en)	2002-03-12	2003-09-25	Merck & Co., Inc.	Substituted amides
US7456222B2 (en)	2002-05-17	2008-11-25	Sequella, Inc.	Anti tubercular drug: compositions and methods
CN101404986B (en)	2002-05-17	2011-09-28	赛奎拉公司	Compositions and pharmaceutical methods for diagnosis and treatment of infectious diseases
US20040033986A1 (en)	2002-05-17	2004-02-19	Protopopova Marina Nikolaevna	Anti tubercular drug: compositions and methods
EP1670314A4 (en)	2003-09-05	2009-02-25	Sequella Inc	Methods and compositions comprising diamines as new anti-tubercular therapeutics
WO2005102331A1 (en) *	2004-04-27	2005-11-03	Santen Pharmaceutical Co., Ltd.	Therapeutic agent for osteoporosis
WO2005102332A1 (en) *	2004-04-27	2005-11-03	Santen Pharmaceutical Co., Ltd.	Therapeutic agent for arthrosis deformans
UA87854C2 (en) *	2004-06-07	2009-08-25	Мерк Энд Ко., Инк.	N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
WO2006035760A1 (en) *	2004-09-27	2006-04-06	Santen Pharmaceutical Co., Ltd.	Drug for treating skin disease
WO2006035759A1 (en) *	2004-09-27	2006-04-06	Santen Pharmaceutical Co., Ltd.	Drug for treating respiratory disease
WO2006043518A1 (en) *	2004-10-18	2006-04-27	Santen Pharmaceutical Co., Ltd.	Drug for treating neurological disease
ES2386365T3 (en) *	2005-01-05	2012-08-17	Abbott Laboratories	Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase enzyme type 1
JP5133702B2 (en) *	2005-01-05	2013-01-30	アボット・ラボラトリーズ	Inhibitors of 11-β-hydroxysteroid dehydrogenase type 1 enzyme
US20090192198A1 (en)	2005-01-05	2009-07-30	Abbott Laboratories	Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
US8562629B2 (en) *	2006-10-24	2013-10-22	Arthrocare Corporation	Suture device having selective needle actuation and related method
EP1935420A1 (en)	2006-12-21	2008-06-25	Merck Sante	2-Adamantyl-butyramide derivatives as selective 11beta-HSD1 inhibitors
WO2009020603A2 (en) *	2007-08-08	2009-02-12	The Scripps Research Institute	Upp amphiphilic alpha-helix mimetics
KR101518525B1 (en)	2007-10-16	2015-05-15	산텐 세이야꾸 가부시키가이샤	Therapeutic agent for trpv1-mediated disease
EP2351566B1 (en) *	2008-10-22	2014-12-10	Santen Pharmaceutical Co., Ltd	Pharmaceutical composition improved in absorption through intestinal tract
RU2404157C1 (en) *	2009-02-16	2010-11-20	Государственное образовательное учреждение высшего профессионального образования Волгоградский государственный технический университет (ВолгГТУ)	Method for synthesis of n-(1-adamantylalkyl)cycloalkylamines
HRP20090186A2 (en)	2009-03-31	2010-10-31	Institut Ruđer Bošković	Adamantane bisurea derivates, method of their preparation and application in anion sensing
US8357939B2 (en) *	2009-12-29	2013-01-22	Siltronic Ag	Silicon wafer and production method therefor
CA2930584A1 (en)	2013-11-15	2015-05-21	The Wistar Institute Of Anatomy And Biology	Ebna1 inhibitors and their method of use
WO2016183534A1 (en)	2015-05-14	2016-11-17	The Wistar Institute Of Anatomy And Biology	Ebna1 inhibitors and methods using same
EP3793546B1 (en)	2018-05-17	2025-11-19	The Wistar Institute	Ebna1 inhibitor crystalline forms, and methods of preparing and using same
CN110423216B (en) *	2019-08-26	2021-01-05	浙江工业大学	2- (1-adamantane carboxamide) ethyl formate compound and preparation method and application thereof
WO2024084056A1 (en) *	2022-10-21	2024-04-25	Etherna Immunotherapies Nv	Ionizable lipids

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2640055A (en) *	1951-01-06	1953-05-26	Warner Hudnut Inc	Amides
CH500979A (en) *	1967-02-16	1970-12-31	Shimamoto Takio	Cpds. of formula (I): where R1, R2 = H, alkyl, aryl or aralkyl, or R1 + R2 = bivalent cyclic alkyl group, R3 = alkyl, OH, alkoxy, amino, alkylamino or dia
US3682922A (en) *	1969-01-16	1972-08-08	Searle & Co	N-acyl-n-{8 (n{40 ,n{40 -disubstituted amino)-alkyl{9 -1-adamantylmethylamines
US4597902A (en)	1981-05-20	1986-07-01	A. H. Robins Company, Incorporated	N-(arylthioalkyl)-N'-(aminoalkyl)ureas
US4724235A (en)	1981-05-20	1988-02-09	A. H. Robins Company, Incorporated	N-(arylthioalkyl)-N'-(aminoalkyl)ureas useful in the treatment of arrhythmia
US4555515A (en) *	1985-02-25	1985-11-26	Stauffer Chemical Co.	Pyridylpropyl carbamates as insect repellents
US5599944A (en) *	1987-03-24	1997-02-04	Bayer Aktiengesellschaft	Intermediates for herbicidal sulphonylaminocarbonyltriazolinones having substituents which are bonded via sulphur
US5776963A (en) *	1989-05-19	1998-07-07	Hoechst Marion Roussel, Inc.	3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
FR2664269B1 (en) *	1990-07-05	1992-10-02	Roussel Uclaf	NOVEL N-SUBSTITUTED DERIVATIVES OF ALPHA-MERCAPTO ALKYLAMINES, THEIR PREPARATION PROCESS, THEIR APPLICATION AS MEDICAMENTS AND THE COMPOSITIONS CONTAINING THEM.
US5173506A (en)	1990-08-16	1992-12-22	Schering Corporation	N-(mercaptoalkyl)ureas and carbamates
WO1992007567A1 (en)	1990-11-06	1992-05-14	Smithkline Beecham Corporation	Imidazolidinone compounds
NZ242054A (en) *	1991-03-22	1993-11-25	British Tech Group	Pyridine derivatives having a bridged alicyclic group; medicaments
GB9401129D0 (en)	1994-01-21	1994-03-16	British Bio Technology	Hydroxamic acid derivatives as metalloproteinase inhibitors
FI964340A0 (en) *	1994-04-29	1996-10-28	Pfizer	New acyclic and cyclic amides as activators for neurotransmitter releasing agents
EP0849256B1 (en) *	1995-08-22	2005-06-08	Japan Tobacco Inc.	Amide compounds and use of the same
GB9526558D0 (en) *	1995-12-27	1996-02-28	Fujisawa Pharmaceutical Co	Heterobicyclic derivatives
GB9526560D0 (en)	1995-12-27	1996-02-28	Bayer Ag	Use of 2-Amino-Heterocycles
CA2242877A1 (en) *	1996-01-16	1997-07-24	Merck & Co., Inc.	Integrin receptor antagonists
IT1283637B1 (en) *	1996-05-14	1998-04-23	Italfarmaco Spa	COMPOUNDS WITH ANTI-INFLAMMATORY AND IMMUNOSOPPRESSIVE ACTIVITY
JP2001506257A (en)	1996-12-17	2001-05-15	藤沢薬品工業株式会社	Piperazine compounds as MMP or TNF inhibitors
EP0903434B1 (en)	1997-09-17	2002-11-27	Lenzing Aktiengesellschaft	Process for the treatment of cellulosic fibres
DE59806420D1 (en)	1997-09-17	2003-01-09	Chemiefaser Lenzing Ag	Process for the treatment of cellulose fibers
JP3603177B2 (en)	1998-03-26	2004-12-22	参天製薬株式会社	New urea derivatives
CN1305846C (en)	1998-03-26	2007-03-21	参天制药株式会社	Urea Derivatives
JP3472917B2 (en)	1998-08-05	2003-12-02	参天製薬株式会社	Novel urea derivatives having a nitrogen-containing aromatic heterocycle
WO2000007985A1 (en) *	1998-08-05	2000-02-17	Santen Pharmaceutical Co., Ltd.	Novel urea derivatives bearing nitrogenous aromatic heterocycles
WO2000056725A1 (en) *	1999-03-19	2000-09-28	Du Pont Pharmaceuticals Company	N-adamant-1-yl-n'-[4-chlorobenzothiazol-2-yl] urea useful in the treatment of inflammation and as an anticancer radiosensitizing agent
KR20010112408A (en)	1999-04-07	2001-12-20	모리타 다카카즈	N-Substituted-N'-Substituted urea derivative and use thereof as TNF-αproduction inhibitor
DE29910780U1 (en) *	1999-06-21	1999-09-16	Hahn Schickard Ges	Holding and actuating device
EP1302461B1 (en) *	2000-05-31	2007-09-26	Santen Pharmaceutical Co., Ltd.	Tnf-alpha production inhibitors
CN100522150C (en)	2001-11-30	2009-08-05	参天制药株式会社	Angiogenesis inhibitor

2001
- 2001-05-31 EP EP01934447A patent/EP1302461B1/en not_active Expired - Lifetime
- 2001-05-31 ES ES05290274T patent/ES2353020T3/en not_active Expired - Lifetime
- 2001-05-31 EP EP05290274A patent/EP1568692B1/en not_active Expired - Lifetime
- 2001-05-31 AU AU6067401A patent/AU6067401A/en active Pending
- 2001-05-31 CN CNB018102336A patent/CN1284771C/en not_active Expired - Fee Related
- 2001-05-31 DK DK01934447T patent/DK1302461T3/en active
- 2001-05-31 AT AT01934447T patent/ATE374186T1/en active
- 2001-05-31 AT AT05290275T patent/ATE358122T1/en not_active IP Right Cessation
- 2001-05-31 DE DE60127595T patent/DE60127595T2/en not_active Expired - Lifetime
- 2001-05-31 AT AT05290274T patent/ATE481385T1/en not_active IP Right Cessation
- 2001-05-31 EP EP06076696A patent/EP1743885B1/en not_active Expired - Lifetime
- 2001-05-31 KR KR1020087023872A patent/KR100978304B1/en not_active Expired - Fee Related
- 2001-05-31 CN CNB2004100546746A patent/CN1307159C/en not_active Expired - Fee Related
- 2001-05-31 AT AT06076696T patent/ATE448204T1/en not_active IP Right Cessation
- 2001-05-31 WO PCT/JP2001/004586 patent/WO2001092229A1/en not_active Ceased
- 2001-05-31 EP EP05290275A patent/EP1561749B1/en not_active Expired - Lifetime
- 2001-05-31 ES ES06076696T patent/ES2339141T3/en not_active Expired - Lifetime
- 2001-05-31 AU AU2001260674A patent/AU2001260674B2/en not_active Ceased
- 2001-05-31 JP JP2001164523A patent/JP3867196B2/en not_active Expired - Fee Related
- 2001-05-31 CN CNB200410054677XA patent/CN1324012C/en not_active Expired - Fee Related
- 2001-05-31 PT PT01934447T patent/PT1302461E/en unknown
- 2001-05-31 CA CA2736344A patent/CA2736344A1/en not_active Abandoned
- 2001-05-31 ES ES05290275T patent/ES2284138T3/en not_active Expired - Lifetime
- 2001-05-31 US US10/168,777 patent/US7098226B2/en not_active Expired - Fee Related
- 2001-05-31 DE DE60140495T patent/DE60140495D1/en not_active Expired - Lifetime
- 2001-05-31 KR KR1020027016230A patent/KR100880698B1/en not_active Expired - Fee Related
- 2001-05-31 DE DE60130658T patent/DE60130658T2/en not_active Expired - Lifetime
- 2001-05-31 CA CA2409741A patent/CA2409741C/en not_active Expired - Fee Related
- 2001-05-31 ES ES01934447T patent/ES2293993T3/en not_active Expired - Lifetime
- 2001-05-31 DE DE60143098T patent/DE60143098D1/en not_active Expired - Lifetime
2002
- 2002-11-28 NO NO20025718A patent/NO324472B1/en not_active IP Right Cessation
2006
- 2006-02-28 AU AU2006200864A patent/AU2006200864B2/en not_active Ceased
- 2006-05-19 JP JP2006140241A patent/JP4482735B2/en not_active Expired - Fee Related
- 2006-06-07 US US11/448,634 patent/US7491739B2/en not_active Expired - Fee Related
- 2006-06-22 US US11/472,603 patent/US7345064B2/en not_active Expired - Fee Related
2007
- 2007-06-29 NO NO20073371A patent/NO20073371L/en not_active Application Discontinuation
- 2007-08-15 US US11/893,238 patent/US20080182881A1/en not_active Abandoned
- 2007-12-14 CY CY20071101588T patent/CY1107089T1/en unknown
2009
- 2009-09-23 US US12/586,515 patent/US7923461B2/en not_active Expired - Fee Related
- 2009-12-14 JP JP2009283085A patent/JP2010059205A/en active Pending
- 2009-12-14 JP JP2009283084A patent/JP2010059204A/en active Pending

Publication	Publication Date	Title
AU2001260674A1 (en)	2002-02-28	TNF-alpha production inhibitors
AU2001234088A1 (en)	2001-11-08	TNF-alpha inhibitors
AU2001258771A1 (en)	2001-11-26	-secretase inhibitors
AU2002219555A1 (en)	2003-01-23	VLA-4 Inhibitors
AU2001242886A1 (en)	2001-10-03	Subsea production system
AU2001268441A1 (en)	2002-01-02	Smart blocks
AU3408801A (en)	2001-08-27	Tnf-alpha inhibitors
AU2002223589A1 (en)	2002-04-15	Production of polypropylene
AU2001296961A1 (en)	2002-04-08	17-beta-hydroxysteroid dehydrogenase-ii inhibitors
AU2001285750A1 (en)	2002-03-14	Urokinase inhibitors
AU2001236052A1 (en)	2001-11-29	Urease inhibitors
AU2002222627A1 (en)	2002-06-24	Tak1 inhibitors
AU2001255090A1 (en)	2001-11-12	Cdk inhibitors having 3-hydroxychromen-4-one structure
AU2001230207A1 (en)	2001-08-20	Method for the production of 1-amino-3-aryl-uracils
AU2001232245A1 (en)	2001-08-20	Tnf- alpha inhibitors
AU2001291313A1 (en)	2002-04-22	Process for making 3-amino-2-chloro-4-methylpyridine
AU7445100A (en)	2001-04-30	Sebum production inhibitors
AU1588901A (en)	2001-06-06	Protease inhibitors
AU2001266176A1 (en)	2002-01-14	Methods
AU2001265935A1 (en)	2002-01-14	Production of biohydrolysates
AU2002218440A1 (en)	2002-07-01	New process
AU1474601A (en)	2001-06-06	Protease inhibitors
AU1474701A (en)	2001-06-06	Protease inhibitors
AU2001278997A1 (en)	2002-02-13	Thrombin inhibitors
AU2002342682A1 (en)	2002-11-25	Protease inhibitors